Other languages EVT Limited

Equities

EVT

AU000000EVT1

Delayed Australian S.E. Other stock markets 11:57:40 2024-05-08 pm EDT			5-day change	1st Jan Change
12.05 ^AUD	-0.66%		+1.43%	-1.55%

Apr. 30	Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	MT
Apr. 24	Germany's Evotec Appoints Permanent CEO	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evotec, Bayer to Focus on Precision Treatments for Cardiovascular Diseases	Apr. 30
Germany's Evotec Appoints Permanent CEO	Apr. 24
EVT's Net Profit Declines 72% in Fiscal H1 on Thredbo Impact	Feb. 15
EVT Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 14
Evotec's US Unit Expands Collaboration vs HIV with Advanced BioScience Laboratories	Feb. 07
Evotec Reiterates Trading Regulations Compliance Amid Former CEO’s Late Stock Trades Disclosure	Jan. 22
Evotec Receives $25 Million Under Neuroscience Collaboration with Bristol Myers Squibb	Jan. 08
Correction: Evotec, Owkin Team Up on AI-powered Research Across Oncology, Immunology, Inflammation	Jan. 04
Evotec, Owken Team Up on AI-powered Research Across Oncology, Immunology, Inflammation	Jan. 04
Evotec CEO to Step Down in 2026; Interim Successor Appointed	Jan. 04
Evotec Secures Grant for Teratogenicity Platform	Dec. 19
Evotec Partners With German Institution for Expanded Autoimmune Diseases Patients Database; Shares Up	Dec. 14
Evotec, Glycotope Partner on Immune Cell Bispecifics Development Against Tumor	Dec. 11
Evotec Signs Strategic Oncology-focused Partnership With Dewpoint Therapeutics	Nov. 07
EVT Limited Provides Earnings Guidance for the Full Year 2023	23-10-19
Evotec Grants Three Partners Access to R&D Platform in Support of Biotech Innovation	23-09-27
Evotec, Novo Nordisk Partner for Translational Drug Discovery Accelerator	23-09-26
EVT Limited Announces Ordinary Fully Franked Dividend for the Twelve Months Ended June 30, 2023, Payable on September 28, 2023	23-08-27
EVT Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-27
EVT Limited acquired Freehold interest in 54 Cook Street, Auckland for NZD 32.2 million.	23-08-27

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages EVT Limited

Equities

EVT

AU000000EVT1

Other languages

Filters